Bioinformatics to Boost Metagenomic Sequence Market

Market Research Future (MRFR) in their recently published report on the metagenomic sequence market, declared that the market could expect 6.5% CAGR during the forecast period (2017-2023). The metagenomic sequence is sampling of genomes which helps in the study of microbial communities with a broad range of applications, right from healthcare to energy. The sampling ensures that the prior isolation and cultivation of species do not take place and maintain a natural habitat. The market is gaining much from the latest technologies that are getting implemented, such as the shotgun method and high-through-put sequencing. MRFR in their report on the metagenomic sequence market takes a peek into the drivers that can significantly impact the market. At the same time, a detailed discussion of the segments can provide greater insight about the upcoming market.

Major factors that are changing the market dynamics are increasing scope to explore the biodiversity owing to fall in the DNA sequencing cost, investments from the bioinformatics companies, advanced technological platform, and implementation of innovative tools such as Integrated Microbial Genome/Microbiome (IMG/M) which has smoothened the workflow considerably. However, the market can face setbacks owing to lack of trained professionals to handle the market.

Metagenomic Sequence Market Segmentation:

MRFR report reveals the global metagenomic sequencing market as segmented by technology, application, and end-user.

Based on the technology, the global metagenomic sequencing market can be segmented into sequencing, bioinformatics, and others. Bioinformatics is gaining much traction owing to the need for sampling of the microbial communities that were not recorded while trying the traditional modules.

Based on the application, the global metagenomic sequencing market comprises gut microbe characterization, infectious disease diagnosis, environmental remediation, biotechnology, biofuel, ecology, agriculture, and others. Biofuel segment is gaining mileage as demand for reducing fossil fuel is getting stronger.

Based on the end-user, the metagenomic sequencing market can be segmented into hospitals, research institutes, specialized clinics, and others.

Metagenomic Sequence Market Regional Analysis:

Region-specific analysis of the global metagenomic sequencing market as conducted by the MRFR reveals the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

The Americas has the advantage of having a robust infrastructure and substantial government and private spending capability. The region is including all the latest technologies available by investing substantially in the research and development sector.?

The rising adoption of NGS procedure, along with low cost of the process, has been taken up by research laboratories which are driving the European market ahead. The market is also benefitting much from the joint ventures as a strategic move taken by companies.

The APAC market is expected to showcase the fastest growth rate during the forecast period. The region is benefitting majorly from two things, One, the rise of the developing economies who are spending substantially to develop their industrial scenario and the other is the market titans looking at the region as a prospect for market expansion. The region has affordable labor, and raw materials are quite easily available.

Meanwhile, the MEA region may manage only a meager growth due to the presence of several poor economies and lack of necessary infrastructure.

Metagenomic Sequence Market Competitive Landscape:

Major players in the global metagenomic sequencing market to make an impact are GATC Biotech AG (Germany), Biomatters Ltd. (New Zealand), Illumina Inc. (U.S.), Enterome Bioscience (France), Aperiomics, Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), SciGenom Labs Pvt. Ltd. (India),?Second Genome Therapeutics (U.S.), Freenome Inc. (U.S.), GenapSys, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), COSMOSID (U.S.), Pacific Biosciences (U.S.), Quest Diagnostics Incorporated (U.S.), Beijing Genomics Institute (China), Oxford Nanopore Technologies Inc. (UK), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Helicos BioSciences (U.S.), Knome Inc. (U.S.), and others.

Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/metagenomic-sequencing-market-5598

In 2018, CoreBiome Founders revealed a report where the study shows the shallow-depth (0.5 million reads) and moderate-depth (1-2 million reads) shotgun sequencing can provide similar results like that of amplicon sequencing. The results based on the species-level taxonomic and functional data are quite promising.

About Market Research Future:

At?Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Akash Anand, Market Research Future Office No. 524/528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India +1 646 845 9312